Literature DB >> 4178232

Studies into the occurrence of soluble antigen-antibody complexes in disease. 3. Rheumatoid arthritis and other human diseases.

R Baumal, I Broder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4178232      PMCID： PMC1578954     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  23 in total

1.  STUDIES OF THE ANTIBODY NATURE OF THE RHEUMATOID FACTOR. REACTION OF THE RHEUMATOID FACTOR WITH HUMAN SPECIFIC PRECIPITATES AND WITH NATIVE HUMAN GAMMA GLOBULIN.

Authors:  K AHO; K SIMONS
Journal:  Arthritis Rheum       Date:  1963-12

Review 2.  THE ROLE OF ANTIGEN-ANTIBODY COMPLEXES IN DISEASE.

Authors:  F J DIXON
Journal:  Harvey Lect       Date:  1963

3.  ANTIGEN EXCESS IN GUINEA PIG ANAPHYLAXIS.

Authors:  O L FRICK; P LIACOPOULOS; S RAFFEL
Journal:  J Immunol       Date:  1965-06       Impact factor: 5.422

4.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

5.  Presence of aggregated gamma-G-globulin in certain rheumatoid synovial effusions.

Authors:  K Hannestad
Journal:  Clin Exp Immunol       Date:  1967-07       Impact factor: 4.330

6.  Biologic activities of aggregated gamma-globulin. 8. Aggregated immunoglobulins of different classes.

Authors:  T Ishizaka; K Ishizaka; S Salmon; H Fudenberg
Journal:  J Immunol       Date:  1967-07       Impact factor: 5.422

7.  Physicochemical properties of reaginic antibody. V. Correlation of reaginic activity wth gamma-E-globulin antibody.

Authors:  K Ishizaka; T Ishizaka; M M Hornbrook
Journal:  J Immunol       Date:  1966-12       Impact factor: 5.422

8.  Studies into the occurrence of soluble antigen--antibody complexes in disease. I. A biological assay for soluble complexes.

Authors:  R Baumal; I Broder
Journal:  Clin Exp Immunol       Date:  1968-07       Impact factor: 4.330

9.  Human serum necrotizing factor: basic properties and clinical significance.

Authors:  R W Moskowitz
Journal:  J Lab Clin Med       Date:  1965-12

10.  Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement.

Authors:  W Dias Da Silva; I H Lepow
Journal:  J Exp Med       Date:  1967-05-01       Impact factor: 14.307
View more
  12 in total

1.  Lymphocyte subpopulations in rheumatoid synovial tissue.

Authors:  A Wangel; M Klockars
Journal:  Ann Rheum Dis       Date:  1977-04       Impact factor: 19.103

2.  Response to autologous immunoglobulin G in patients with rheumatoid arthritis.

Authors:  M A Chamberlain; C G Shapland; I M Roitt
Journal:  Ann Rheum Dis       Date:  1970-03       Impact factor: 19.103

3.  Studies into the occurrence of soluble antigen-antibody complexes in disease. II. Criteria for distinguishing soluble complexes from other macromolecular histamine releasers.

Authors:  I Broder; R Baumal; E Keystone
Journal:  Clin Exp Immunol       Date:  1968-07       Impact factor: 4.330

4.  Complement-fixing activity of rheumatoid synovial fluid.

Authors:  A S Townes; R L Marcus
Journal:  Ann Rheum Dis       Date:  1972-09       Impact factor: 19.103

5.  Studies on circulating soluble immune complexes of the liver disease. 2. Serum inhibitory activity of polyclonal rheumatoid factor binding to IgG-sepharose.

Authors:  J Narumoto; T Arima; K Kunishi; T Yasuhara; K Suwaki; H Shimomura; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1979-12

6.  Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis. Partial characterization and relationship to lowered complement levels.

Authors:  R J Winchester; V Agnello; H G Kunkel
Journal:  Clin Exp Immunol       Date:  1970-05       Impact factor: 4.330

7.  Studies into the occurrence of soluble antigen-antibody complexes in disease. VI. Further characterization of the biological and physical properties of the rheumatoid biologically active factor (RBAF).

Authors:  I Broder; E Tackaberry; M Urowitz; L Russell; R Baumal
Journal:  Clin Exp Immunol       Date:  1974-05       Impact factor: 4.330

8.  Studies of cryoprecipitates from synovial fluid of rheumatoid patients.

Authors:  A Cracchiolo; L S Goldberg; E V Barnett; R Bluestone
Journal:  Immunology       Date:  1971-06       Impact factor: 7.397

9.  Studies into the occurrence of soluble antigen-antibody complexes in disease. IV. Correlation between the rheumatoid biologically active factor and the clinical features of rheumatoid arthritis.

Authors:  D A Gordon; D A Bell; R Baumal; I Broder
Journal:  Clin Exp Immunol       Date:  1969-07       Impact factor: 4.330

10.  Complement-fixing material in ther sera of patients with rheumatoid arthritis.

Authors:  F C McDuffie; G G Hunder; R J Clark
Journal:  Clin Exp Immunol       Date:  1978-05       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.